References
- American Diabetes AssociationEconomic costs of diabetes in the U.S. in 2007Diabetes Care20083159661518308683
- American Diabetes AssociationStandards of medical care in diabetes – 2008Diabetes Care200831Suppl 1S12S5418165335
- CramerJAA systematic review of adherence with medications for diabetesDiabetes Care20042751218122415111553
- CatalanVSCoutureJALelorierJPredictors of persistence of use with the novel antidiabetic agent acarboseArch Intern Med20011611106111211322845
- DaileyGKimMSLianJFPatient compliance and persistence with antihyperglycemic drug regimens: evaluation of a medicaid patients population with type 2 diabetes mellitusClin Ther2001231311132011558867
- DeziiCMKawabataHTranMEffects of once-daily and twice-daily dosing on adherence with prescribed glizipide oral therapy for type 2 diabetesSouth Med J200295687111827247
- OliveriaSAMendittoLAUlcickas YoodMKooYHWellsKEMcCarthyBDBarriers to the initiation of, and persistence with, insulin therapyCurr Med Res Opin200723123105311217977482
- PaesAHBakkerASoe-AgnieCJImpact of dosage frequency on patient complianceDiabetes Care19972010151215179314626
- OdegardPSCapocciaKMedication taking and diabetes: a systematic review of the literatureDiabetes Educ20073361014102918057270
- PetersonAMNauDPCramerJABennerJGwadry-SridharFNicholMA checklist for medication compliance and persistence studies using retrospective databasesValue Health200710131217261111
- DeyoRACherkinDCCiolMAAdapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJ Clin Epidemiol1992456136191607900
- SikkaRXiaFAubertREEstimating medication persistency using administrative claims dataAm J Manag Care20051144945716044982
- CookeCELeeHYTongYPHainesSTPersistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organizationCurr Med Res Opin201026123123819921965
- HertzRPUngerANLustikMBAdherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insuranceClin Ther2005271064107316154485
- FabunmiRNielsenLLQuimboRPatient characteristics, drug adherence patterns, and hypoglycemia costs for patients with type 2 diabetes mellitus newly initiated on exenatide or insulin glargineCurr Med Res Opin200925377778619203299
- PawaskarMDCamachoFTAndersonRTCobdenDJoshiAVBalkrishnanRHealth care costs and medication adherence associated with initiation of insulin pen therapy in medicaid-enrolled patients with type 2 diabetes: a retrospective database analysisClin Ther20072912941305